Novel therapeutic strategies for MLL-rearranged leukemias
Authors:
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1863 (9) , 194584
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK
- Kay Kendall Leukaemia Fund
This publication has 260 references indexed in Scilit:
- LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanismLeukemia Research, 2012
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem CellsCancer Cell, 2012
- Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone ModificationCell, 2011
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent TranscriptionCancer Cell, 2010
- MLL-AF9-Induced Leukemogenesis Requires Coexpression of the Wild-Type Mll AlleleCancer Cell, 2010
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 LeukemiasCancer Cell, 2008
- Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target GenesCancer Cell, 2008
- Structural Basis for the Methylation State-Specific Recognition of Histone H4-K20 by 53BP1 and Crb2 in DNA RepairCell, 2006